Scaling Up Point-of-Care Hepatitis C Testing and Treatment in Canada (SCALE POCT)
Scaling Up Point-of-Care Hepatitis C Testing and Treatment in Canada: A Multilevel Implementation Science Study of Clinical Processes, Barriers, Facilitators and Implementation Strategies
Sponsor: Action Hepatitis Canada
This observational or N/A phase trial investigates HCV and HEPATITIS C VIRUS CHRONIC INFECTION and is currently actively recruiting participants. Action Hepatitis Canada leads this study, which shows 2 recorded versions since 2025 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
2 versions recorded-
Sep 2025 — Present [monthly]
Recruiting
-
Aug 2025 — Sep 2025 [monthly]
Recruiting
First recorded
May 2025
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Action Hepatitis Canada
- British Columbia Centre for Disease Control
- CATIE
- Canadian Association of People who Use Drugs
- Canadian Institutes of Health Research (CIHR)
- Canadian Liver Foundation
- Canadian Network on Hepatitis C
- Centre de Recherche du Centre Hospitalier de l'Université de Montréal
- International Network on Health and Hepatitis in Substance Users
- Jewish General Hospital
- Lady Davis Institute
- McGill University
- McGill University Health Centre/Research Institute of the McGill University Health Centre
- Ottawa Hospital Research Institute
- Public Health Agency of Canada (PHAC)
- The University of New South Wales
- University of British Columbia
- University of Ottawa
- University of Toronto
- York University
For direct contact, visit the study record on ClinicalTrials.gov .